Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer
Figure 3
The prognostic values of mRNA level of MTs in all GC patients (Kaplan-Meier plotter). Notes: Kaplan-Meier plots show the association between the expression of MTs and OS, FP and PPS in GC patients, respectively, with statistical significance. A1–3: Prognostic HRs of individual MT isoform in all gastric cancer for OS, FP, and PPS. (b) OS curves of MT1F (Affymetrix ID:21716 at); MT1G (Affymetrix ID:21047 at); MT1H (Affymetrix ID:20646 at); MT1X (Affymetrix ID:20432 at); MT3 (Affymetrix ID:20597 at); MT4 (Affymetrix ID:21739 at). (c) FP Curves of MT1E (Affymetrix ID:21285 at); MT1F; MT1G; MT1H; MT1M (Affymetrix ID:21754 at); MT1X; MT3; MT4. (d) PPS curves of MT1G; MT1X; MT2A (Affymetrix ID:21218 at); MT3; MT4. Abbreviations: OS: overall survival; FP: first progression; PPS: postprogression survival; GC: gastric cancer; HR: hazard ratio.